Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
973,841
-
Shares change
-
+60,363
-
Total reported value, excl. options
-
$72,916,745
-
Value change
-
+$4,475,875
-
Number of buys
-
19
-
Number of sells
-
24
-
Price
-
$74.85
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q3 2021
As of 30 Sep 2021 INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) had 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 973,841 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, Artemis Wealth Advisors, LLC, BANK OF AMERICA CORP /DE/, ADVISOR GROUP HOLDINGS, INC., LPL Financial LLC, PFG Advisors, UBS Group AG, and STIFEL FINANCIAL CORP.
This table shows 97 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.